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Chronic low-grade inflammation and increased
serum levels of the cytokine IL-6 accompany obesity.
For brain-produced IL-6, the mechanisms by which it
controls energy balance and its role in obesity
remain unclear. Here, we show that brain-produced
IL-6 is decreased in obese mice and rats in a neuro-
anatomically and sex-specific manner. Reduced IL-6
mRNA localized to lateral parabrachial nucleus
(lPBN) astrocytes, microglia, and neurons, including
paraventricular hypothalamus-innervating lPBN neu-
rons. IL-6 microinjection into lPBN reduced food
intake and increased brown adipose tissue (BAT)
thermogenesis in male lean and obese rats by
increasing thyroid and sympathetic outflow to BAT.
Parabrachial IL-6 interacted with leptin to reduce
feeding. siRNA-mediated reduction of lPBN IL-6
leads to increased weight gain and adiposity,
reduced BAT thermogenesis, and increased food
intake. Ambient cold exposure partly normalizes
the obesity-induced suppression of lPBN IL-6. These
results indicate that lPBN-produced IL-6 regulates
feeding and metabolism and pinpoints (patho)physi-
ological contexts interacting with lPBN IL-6.
INTRODUCTION
Obesity is frequently accompanied by chronic low-grade inflam-
mation and increased serum levels of interleukin-6 (IL-6), an
essential component of the immune response. Elevated IL-6Cell R
This is an open access article under the CC BY-Nlevels result from increased IL-6 production in adipocytes (Roy-
tblat et al., 2000; Stenlöf et al., 2003) and can be normalized by
low-calorie diets (Bastard et al., 2000; Gallistl et al., 2001). This
cytokine clearly has detrimental effects during obesity and
inflammatory disorders. Reducing circulating IL-6 action, by
blocking IL-6 receptors, is approved for the treatment of patients
with rheumatoid arthritis and other inflammatory disorders. Yet IL-
6 function may not be restricted to the immune response during
disease (Benrick et al., 2009; Chida et al., 2006; Erta et al.,
2012; Schéle et al., 2012); IL-6 also may be essential for the
control of metabolism during health. In fact, patients receiving
tocilizumab, IL-6 receptor-inhibiting monoclonal antibodies
approved for clinical use, often suffer from increased weight
gain and dyslipidemia (Febbraio et al., 2010). Likewise, whole-
body IL-6 knockout in mice leads to increased body weight,
subcutaneous fat, and dysregulation of glucosemetabolism (Wal-
lenius et al., 2002b), indicating pleiotropic role of this cytokine.
The CNS is suggested as the main site for the metabolic and
anorexic effects of IL-6 (Timper et al., 2017; Wallenius et al.,
2002a). Key energy balance signals, like leptin, glucagon-like
peptide-1 (GLP-1), and amylin, require intact CNS IL-6 to reduce
food intake and body weight (Le Foll et al., 2015; Shirazi et al.,
2013; Timper et al., 2017). Peripheral and CNS IL-6 systems
are possibly distinct, because elevated serum IL-6 levels in
obesity are not reflected in the CNS, at least not in the cerebro-
spinal fluid, where a surprising reduction of the IL-6 peptide is
revealed in overweight and obese men (Stenlöf et al., 2003).
These data also suggest that the function of peripheral and
CNS IL-6 is likely divergent. The neural circuits and mechanisms
engaged by CNS-produced IL-6 to reduce body weight and
body fat and their role in obesity are poorly understood.
To determine whether brain IL-6 production is affected by
high-fat diet (HFD)-induced obesity, and to narrow the sites ofeports 26, 3011–3026, March 12, 2019 ª 2019 The Author(s). 3011
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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potential interest for the weight- and the fat-controlling role of
IL-6, we initially evaluated IL-6 gene expression in key energy
balance-controlling brain regions in obese male and female
mice. Surprisingly, a very strong reduction in IL-6 gene expres-
sion in HFD-fed mice was only detected in one brain nucleus—
the parabrachial nucleus (PBN)—but not in the hypothalamus.
This was an unexpected finding, because most studies to date
only evaluate the hypothalamus as the main neural substrate
for the weight loss effects of IL-6 (Benrick et al., 2009; Le Foll
et al., 2015; Schéle et al., 2012; Timper et al., 2017).
While the lateral PBN (lPBN) is a brain nucleus that received
much less attention for its role in food intake and energy expen-
diture control compared to the hypothalamus, we and others
have previously demonstrated that it receives energy-balance-
relevant anorexigenic inputs from, e.g., leptin, GLP-1, and mela-
nocortin (Alhadeff et al., 2014a, 2014b; Flak et al., 2014; Richard
et al., 2014; Shah et al., 2014). Indirect activation of lPBN results
in severe anorexia in mice indicating a powerful position of this
nucleus in feeding control (Wu et al., 2009).
Using genetic, molecular, and pharmacological manipula-
tions, the lPBNwas evaluated as a potential previously unknown,
but critical site of, the anorexic action of IL-6, capable of produc-
ing and responding to IL-6, in a sex-specific manner, in obesity.
Utilizing a recently developed retrograde neuronal tracing strat-
egy, we assessed lPBN as a potential source of IL-6 to the
hypothalamus. Moreover, the ability of lPBN IL-6 to control ther-
mogenesis, both via neural and hormonal mechanisms, was
determined. Since IL-6 was previously shown to enhance intra-
cellular signaling induced by the anorexic adipose hormone, lep-
tin, in the hypothalamus (Larsen et al., 2016; Le Foll et al., 2015),
we assessed the cooperative interaction of IL-6 and leptin in
feeding and thermogenesis at the level of the lPBN. Finally, we
determined whether thermogenic contexts other than obesity,
namely, cold exposure and stress, affect lPBN IL-6.Figure 1. Interaction of IL-6 Gene Expression with Sex and Diet in the
(A–F) Mice, 5 weeks old at the start of the experiment, were fed a normal chow or
respective diet.
(A) Body weight of male mice at 13 weeks of age (n = 10, for all groups).
(B) IL-6 gene expression in male mice in the parabrachial nucleus as detected b
(C) Expression of other inflammation-associated genes (n = 8–9) in male mice in
(D) qPCR of IL-6 expression in other food intake-associated brain regions in m
(n = 6–10).
(E) Body weight of female mice at 13 weeks old (n = 10, for all groups).
(F) qPCR of IL-6 and IL-1 gene expression in the parabrachial nucleus of female
(G) Body weight of male rats on a high-fat/high-sugar diet (n = 5).
(H) White adipose tissue mass in male rats on a chow or a high fat/high-sugar di
(I) IL-6 gene expression, as detected by qPCR, in male rats maintained on a cho
(J and K) Body weight (J) and IL-6 expression (K) in female rats maintained on a
(L–S) IL-6 mRNA is displayed in green, and cell nuclei is displayed in blue (DAPI)
(L) Lateral parabrachial nucleus IL-6 mRNA was detected using fluorescent in sit
(M–P) DAPI (M), IL-6 (N), DAPI with IL-6 (O), and a high-resolution image of singl
(Q–S) To understand the cellular origin of IL-6 in the lPBN, we used RNAScope to c
microglial (AIF1; gray; S) mRNA markers. Gene expression data were normalize
parabrachial nucleus; Il-6, interleukin-6; Il-1, interleukin-1; Il-6r, IL-6 receptor; Tn
inguinal white adipose tissue; X, cycle threshold values in real-time PCR were out
low to be evaluated and compared.
For comparison of male and female IL-6 gene expression, see Figure S1. For result
with IL-6 mRNA, see Figure S2. All gene expression presented here as bar grap
**p < 0.005; ***p < 0.001; compared with respective controls, unpaired Student’sRESULTS
Potently Reduced IL-6 Expression in the PBN of Obese
Male Mice and Rats
How CNS IL-6 production is affected by obesity is poorly un-
derstood; thus, we investigated the effect of HFD exposure
on IL-6 gene expression in the PBN. For both mice and rats,
the choice of an obesogenic diet was based on in-house
testing designed to find the most effective diet at inducing hy-
perphagia and obesity in each species. As a result, mice were
fed regular chow (Global Diet #2016; Harlan-Teklad; 4% kcal
from fat) or HFD (catalog #D12492; Research Diets; 60%
kcal from fat) previously shown to increase visceral fat, pro-
duce hyperinsulinemia, and insulin resistance after an 8-week
exposure (Della Vedova et al., 2016; Lin et al., 2000). Male or
female Sprague-Dawley CD rats were offered chow and water
or exposed to a high-fat/high-sugar diet consisting of ad libi-
tum access to chow, or lard and sucrose (50%/50% mix),
and water (Diepenbroek et al., 2017). Eight weeks of HFD
feeding increased the body weight of male (p < 0.001, Fig-
ure 1A) and female mice (Figure 1E). The mRNA levels of
PBN IL-6 were significantly reduced in male (p < 0.0001, Fig-
ure 1B), but not in female, mice (Figure 1F). To clarify whether
these changes coexisted with general inflammatory markers,
we assessed the PBN gene expression of IL-1 and tumor ne-
crosis factor alpha (TNF-a), two classic inflammatory markers.
Their expression, in contrast to IL-6, was not altered in diet-
obese mice (Figure 1C, males; Figure 1F, females). Further,
IL-6 levels were unaltered in other food intake-associated re-
gions, such as hypothalamus, amygdala, and hippocampus
(Figure 1D), suggesting that decrease in Il-6 mRNA levels
was not a global response to HFD diets. Next, we investigated
whether the obesity-associated reduction in PBN IL-6 expres-
sion, detected in male mice, also occurs in male rats. AsParabrachial Nucleus
a high-fat diet for 8 weeks. Measurements shown were taken at 8 weeks on the
y qPCR.
the parabrachial nucleus as detected by qPCR.
ale mice, hypothalamus (HYP), amygdala (AMYG), and hippocampus (HIPP)
mice. IL-1 was below the detection threshold.
et.
w or a high-fat/high-sugar diet, 14 weeks on the tissue collection day.
chow or a high-fat/high-sugar diet for 14 weeks.
.
u hybridization (RNAScope).
e cells in the lPBN showing IL-6 and DAPI (P).
o-localize IL-6mRNAwith neuronal (Rbfox3; red; Q), glial (GFAP; orange; R), or
d to the housekeeping gene Ppia and are presented as mean ± SEM. PBN,
f-a, tumor necrosis factor alpha; GWAT, gonadal white adipose tissue; IWAT,
of the defined threshold point of 40 cycles, indicating that IL-1 levels were too
s of approximate quantification of co-expression of each of the cellular markers
hs was detected by real-time qPCR. Data represent mean ± SEM. *p < 0.05;
t test comparisons.
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Figure 2. IL-6 Acts in the lPBN to Reduce Food Intake and Increase
Thermogenesis
(A) Representative confocal image of the injection site pasted into the corre-
sponding rat brain atlas section is displayed.
(B–M) IL-6 or vehicle control was microinjected in the lPBN of male rats.
(B) Chow intake was measured 1 h and 6 h post-injection.
(C) Core temperature was measured every minute for 5 h post-injection. In-
jections were performed at 10.00.
(D) Core temperature averaged over 4 h starting immediately post-injection.
(E) Spontaneous activity was measured for 5 h post-injection. Injections were
performed at 10.00.
(F) Cumulative spontaneous locomotor activity over 4 h.
(G and H) Representative images of rat infrared thermographic pictures used
to assess BAT temperature after vehicle (G) and IL-6 injection (H).
(I) BAT temperature was measured 4 h–5 h post-IL-6 microinjections into the
lPBN in another cohort of rats and compared to controls.
(J–M) Intra-lPBN IL-6 was injected in another cohort of rats fed a high-fat/high-
sugar-fed diet for 3 weeks at the time of testing and food intake expressed as
total calories consumed (J), chow intake (K), sucrose solution intake (L), and
lard intake (M) were measured 6 h post-IL-6 microinjections. BAT, brown
adipose tissue; lPBN, lateral parabrachial nucleus; IL-6, interleukin-6; VEH,
artificial cerebrospinal fluid.
Data represent mean ± SEM. *p < 0.05, paired comparisons Student’s t test.
n = 5–9.
3014 Cell Reports 26, 3011–3026, March 12, 2019expected, the high-fat/high-sugar diet-fed rats gained signifi-
cantly more weight than did controls (p < 0.05, Figure 1G)
and significantly more gonadal and inguinal white adipose tis-
sue (GWAT and IWAT) (p < 0.05, Figure 1H). Most importantly,
they had reduced levels of Il-6 mRNA in the PBN (p < 0.05, Fig-
ure 1I). Female rats, on the other hand, followed the same
pattern as female mice and did not show any significant reduc-
tion in PBN IL-6 expression (Figure 1K), despite a significant
weight gain (Figure 1J).
In the lPBN, Neurons, Astrocytes, and Microglia Contain
IL-6 mRNA
In situ fluorescent hybridization indicated the clear presence of
IL-6 mRNA throughout lPBN (Figures 1L–1P). Outside of the
lPBN or in cell cultures, neurons, astrocytes, and microglia
are capable of producing IL-6 in response to gut-brain signals
(Hidalgo et al., 2010; Le Foll et al., 2015; López-Ferreras
et al., 2018; Shirazi et al., 2013); which cell type produces IL-6
in the lPBN is unknown. As indicated in Figure 1, Il-6 mRNA
was found to be co-expressed with neuronal (Rbfox3; Fig-
ure 1Q), glial (GFAP; Figure 1R), and microglial (Aif1; Figure 1S)
mRNA, indicating that IL-6 can be produced by all three cell
types. Approximate quantification of the co-expression of IL-6
with the three marker mRNAs indicated that neurons are the
major source of IL-6 in the lPBN, followed by astrocytes and
microglia (Figure S2).
IL-6 Acts in the lPBN to Reduce Food Intake and
Increase Body Temperature
We investigated whether IL-6 plays a role in regulating body
weight or energy expenditure through actions in the lPBN.
IL-6 lPBN microinjection led to a significant reduction in
chow intake 6 h after injection (Figure 2B). Lateral PBN-
injected IL-6 also produced hyperthermia (p < 0.05, Figures
2C and 2D) without affecting spontaneous home-cage activ-
ity (p > 0.05, Figures 2E and 2F). Thermal imaging revealed
Figure 3. Cooperative Interaction of Leptin
and IL-6 at the Level of the lPBN
(A–I) Leptin was microinjected into the lPBN of 11-
week-old male rats.
(A) Chow intake was continuously measured
(minute by minute) immediately starting after in-
jections as displayed on the line graph (n = 6).
(B–D) Cumulative chow intake at the following time
points: 6 h (B), 12 h (C), and 24 h (D), as indicated
with black arrows on the line graph.
(E) Body weight 24 h post-lPBN leptin microinjec-
tions.
(F) Core body temperature was telemetrically
collected every 5 min in another group of rats
(n = 18) microinjected with leptin into the lPBN.
(G) Core temperature is averaged over the 6 h
post-injection time period.
(H) Spontaneous home-cage locomotor activity
was telemetrically collected (n = 18) in rats micro-
injected with leptin into the lPBN.
(I) Sum of all post-injection locomotor counts
accumulated for 6 h post-injections.
(J and K) In a new cohort of 11-week-old male rats
(n = 12) chow intake and BAT temperature were
measured after intra-lPBN delivery of sub-
threshold doses of IL-6 (0.1 mg) or leptin (0.1 mg)
alone, or delivery of the two substances together
into the lPBN. (J) Cumulative chow intake collected
over 6 h post-injections. (K) BAT temperature
measured with infrared thermography displayed
as temperature change from pre-injection baseline
to 4–5 h after injections (n = 12).
(L) Representative confocal image of a cannula
tract in lPBN. lPBN, lateral parabrachial nucleus;
IL-6, interleukin-6; BAT, brown adipose tissue.
For intra-lPBN effect of leptin on heart rate, see
Figure S3, and for effect of the combination of
leptin and IL-6 on 24-h chow intake, see Figure S4,
and on tail temperature, see Figure S5. Data
represent mean ± SEM. *p < 0.05; **p < 0.01; two-
way ANOVA (J and K) and one-way ANOVA (B–E,
G, and I) were used for comparisons with Sidak’s
post hoc test.that IL-6 lPBN treatment increased brown adipose tissue
(BAT) temperature (p < 0.05, Figure 2I, representative images:
Figures 2G and 2H). Notably, the hypophagic effect of IL-6
in the lPBN persisted under obesogenic diet feeding condi-
tions (p < 0.05, Figure 2J). Chow and sugar solution intakes
were significantly decreased (p < 0.05, Figures 2K and 2L),
whereas lard intake was unaffected (Figure 2M). The caloric
intake of chow and high-fat/high-sugar diet-fed rats injected
with IL-6 was 55% and 78% of the vehicle group for chow
and high-fat/high-sugar diet-fed rats respectively. Even
though it appears that the intake reduction was less effective
under the high-fat/high-sugar diet-fed condition, this differ-
ence did not reach statistical significance (p = 0.3). Alterna-
tively, because we offered chow, sucrose, and lard sepa-
rately, and the intake of chow was potently reduced, whileCell Rethe intake of lard was not altered, lPBN
IL-6 may be more effective at reducing
intake of specific macronutrients (Bod-nar, 2018; Myers, 2018; Sclafani, 2016; Sclafani and Ackroff,
2016).
Leptin Acts in the lPBN to Alter Food Intake, but Not
Body Temperature
Leptin receptor is expressed in the PBN of mice and rats (Elm-
quist et al., 1998; Grill et al., 2002) and phosphorylation of
STAT3 can be induced in the lPBN by peripheral leptin adminis-
tration (Hosoi et al., 2002). The leptin receptor partly shares
downstream signaling (including pSTAT3) with IL-6Ra (Dunn-
Meynell et al., 2016). Leptin and IL-6 are related structurally,
and both ligands produce anorexia by acting on the lPBN. Lep-
tin, microinjected in the lPBN suppressed food intake when
applied at the start of the dark cycle (active period) or during
the mid-light cycle (inactive period) (Figures 3A, S3C, andports 26, 3011–3026, March 12, 2019 3015
Figure 4. Disrupted Feeding and Body Weight Control in lPBN IL-6 Knockdown
(A) Representative image of rat coronal brain atlas drawing and male rat tissue section showing lPBN-targeted AAV infusions.
(B–E) GFP expression (B), DAPI (C), and the two signals together showing AAV infection (D) in the lPBN cells. High-resolution DAPI (in cyan: A; in blue: C–E).
(legend continued on next page)
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S3D), data in linewith one previous report (Alhadeff et al., 2014b).
Cumulative chow intake was decreased at 6 h (F (2, 10) = 5.496,
p < 0.05; Figure 3B), 12 h (F(2, 10) = 6.685, p < 0.05; Figure 3C),
and 24 h (F(2, 10) = 7.464, p < 0.05; Figure 3D) time points, leading
to a decreased body weight measured at 24 h (F(2, 12) = 7.55,
p < 0.01; Figure 3E). In contrast to IL-6, core body temperature
was not altered by lPBN leptin treatment (F(2, 34) = 1.765,
p > 0.05; Figures 3F and 3G), and spontaneous locomotor activ-
ity was increased (Figures 3H and 3I; F(2, 34) = 3.493, p < 0.05).
Leptin treatment did not affect heart rate (Figures S3A and
S3B). This is in contrast to leptin’s effect in the NTS, where
both body temperature and heart rate are clearly increased by
the same doses of leptin as those applied here in the lPBN (Ski-
bicka and Grill, 2009).
Cooperative Interaction of Leptin and IL-6 on Food
Intake Control
Since both leptin and IL-6 produce an anorexic response by
acting on their receptors in the lPBN, we hypothesized an
interactive relationship between these two signals at the
level of the lPBN. Leptin and IL-6 (both at 0.1 mg) did not affect
food intake, activity, or core temperature, and thus these
ligand doses were labeled as subthreshold and used to
test for a cooperative interaction between these two signals.
Results indicated that IL-6 and leptin indeed interact to
suppress food intake (two-way ANOVA: IL-6 alone: F(1, 11) =
0.21, p > 0.05; leptin alone F(1, 11) = 0.88, p > 0.05; interaction
IL-6 3 leptin F(1, 11) = 0.563, p = 0.05; Figure 3J). This
suppression of chow intake did not persist at 24 h (Figure S4).
BAT region temperature was unaffected (IL-6 alone: F(1, 11) =
4.524, p > 0.05; leptin alone F(1, 11) = 7.652, p < 0.05; interac-
tion IL-6 3 leptin F(1, 11) = 1.528, p > 0.05; Figure 3K). Tail-
surface temperature was also unaffected by IL-6, leptin, or
the combination treatment (Figure S5). These results suggest
that leptin and IL-6 can acutely act in concert, possibly by
sharing a common downstream target, ultimately amplifying
each other’s reduction of food intake. The shared down-
stream signaling is likely to include phosphorylation of
STAT3, at least previous data indicate that ventromedial
hypothalamic leptin signaling is enhanced by induction of
IL-6, which then interacts with its receptors to activate
STAT3 signaling and gene transcription downstream of the
leptin receptor (Le Foll et al., 2015). Moreover, we have previ-
ously shown that both IL-6 and leptin, delivered intracerebro-
ventricularly, induce pSTAT3 in the arcuate nucleus (Anesten
et al., 2017).(F) IL-6 gene expression as detected by qPCR in control rats and rats with siRN
(G) Cumulative body weight gain of the IL-6 KD group compared to controls (n =
(H) Cumulative chow intake in the same rats.
(I–M) Acute light cyclemeasurements over a period of 6 h of total caloric intake (I),
in male rats maintained on a high-fat/high-sugar diet for 3 weeks.
(N) Inguinal white adipose tissue of IL-6 KD (n = 17) in comparison to controls (n
(O) Gonadal white adipose tissue mass in the same rats.
For daily chronic intake on two different obesogenic diets, see Figures S6 and S7.
of rats. IL-6 KD, interleukin-6 knockdown; lPBN, lateral parabrachial nucleus; sc
gonadal white adipose tissue. Data represent mean ± SEM. *p < 0.05; **p < 0.01
Student’s t test when appropriate.Reduction in lPBN IL-6 Leads to Weight and Fat Gain
along with Increased Food Intake
Because we found Il-6 mRNA in the lPBN, along with a modula-
tory effect of IL-6 injections in this area on food intake and core
body temperature, we next set out to determine the physiolog-
ical role of IL-6 in lPBN by evaluating the impact of chronic,
genetic lPBN IL-6 reduction. Adeno-associated virus (AAV)-
small interfering RNA (siRNA) targeting Il-6 mRNA, injected into
the lPBN (representative images of the injection: Figures 4A–
4E), efficiently and specifically reduced Il-6 mRNA in the lPBN
(p < 0.05; Figure 4F), but not in other brain areas (e.g., PVH: rela-
tive delta Ct value of scrambled controls was 12.52 vs. 12.88 of
IL-6 knockdown [KD]). The lPBN IL-6 KD increased body weight
gain (two-way ANOVA, interaction F(17, 544) = 8.345, p < 0.01 and
treatment effect F(1, 32) = 7.548, p < 0.05; Figure 4G) and food
intake (two-way ANOVA: interaction F(17, 544) = 4.944, p < 0.01;
treatment F(1, 32) = 3.462, p > 0.05; Figure 4H) in chow-fed rats.
The onset of increased food intake in lPBN IL-6 KD group (p <
0.05) was observed 12 days following increased weight gain. In
high-fat/high-sugar diet-fed rats, the total amount of calories
consumed over 6 h in the light period was significantly increased
by lPBN IL-6KD (p < 0.01, Figure 4I), with lard (p < 0.05, Figure 4J)
and chow (p = 0.07, Figure 4K), largely driving the increased
intake, while sucrose intake remained unaffected (p > 0.05, Fig-
ure 4L). Water intake was not altered by the lPBN IL-6 reduction
(p > 0.05, Figure 4M). The increased weight gain was also asso-
ciated with increased mass of the subcutaneous IWAT (p < 0.05,
Figure 4N). The weight of GWAT was not altered (p > 0.05, Fig-
ure 4O) by the treatment. The weight gain and long-term hyper-
phagia driven by lPBN IL-6 reduction were not detected in two
separate cohorts of rats fed two different obesogenic diets (Fig-
ures S6 and S7) asmaintenance diets; observation previously re-
ported for IL-6/ mice (Matthews et al., 2010).
PBN IL-6 Knockdown Lowers Core Body Temperature
Changes in body weight after lPBN IL-6 KD emerged prior to the
changes in food intake; therefore, we posited that IL-6 KD
reduced energy expenditure. Since intra lPBN IL-6 delivery
increased core body temperature (Figures 2C and 2D), we hy-
pothesized that lower energy expenditure results from lower
levels of thermogenesis in the IL-6 KD rats. Telemetric moni-
toring of home-cage core body temperature and activity in
lPBN IL-6 KD rats and controls (Figures 5A–5D) indicated that,
in line with our hypothesis, core body temperature was signifi-
cantly lower (p < 0.01, Figure 5B) in lPBN IL-6 KD rats when
compared to controls. The difference in core body temperatureA-mediated knockdown of IL-6 gene (n = 9–12).
17 for all groups). Day 0 represents the day of siRNA introduction.
intake of lard (J), intake of chow (K), intake of sucrose (L), and intake of water (M)
= 17).
The n = 17 reflects data combined from two independent experiments/cohorts
p, superior cerebellar peduncle; IWAT, inguinal white adipose tissue; GWAT,
; #p = 0.07. Two-way ANOVA, followed by Sidak’s post hoc test, or unpaired
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Figure 5. Mechanisms Underlying Disrupted Thermogenesis in lPBN IL-6 Knockdown
(A–S) Virally introduced siRNA, designed to knockdown IL-6 gene expression, was delivered into the lPBN, as shown in Figure 4, and all thermogenic and
locomotor testing was conducted inmale rats 5–6weeks after siRNA introduction. All tissue and plasma sampleswere collected from the same rats 6weeks later.
(A) Core body temperature was telemetrically collected every minute for 48 h (n = 8 each in control and IL-6 KD group).
(B) 48-h average of all collected core temperature values.
(C) Average core temperature of two consecutive dark phases.
(D) Average core temperature from two consecutive light phases.
(E) Spontaneous activity collected every minute for 48 h.
(F) 48-h sum of all collected spontaneous activity values.
(legend continued on next page)
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was present in both the light and dark cycle phases (p < 0.05,
Figures 5C and 5D). During the same data collection period
home-cage activity was not altered (Figures 5E–5H), eliminating
hyperlocomotion as the source of increased energy expenditure
and increased body temperature.
PBN IL-6 Knockdown Decreases BAT Thermogenic
Activity
To understand the mechanisms underlying the reduction in body
temperature, BAT thermogenesis was evaluated using infrared
thermography (representative images presented in Figure 5I)
and revealed that lPBN IL-6 KD rats had lower BAT temperature
(p < 0.05, Figure 5J). Consistent with these results, gene expres-
sion levels of thermogenesis permissive mitochondrial uncou-
pling protein 1 (Ucp1) (Cannon and Nedergaard, 2004; Ulrich-
Lai et al., 2011) were significantly reduced (p < 0.001, Figure 5K)
after IL-6 KD. PR domain zinc-finger protein 16 (Prdm16), a tran-
scription factor recently demonstrated to be required in young
mice to suppress the expression of white-fat-selective genes
in BAT (Harms et al., 2014), was also reduced in rats with
reduced lPBN IL-6 (p < 0.05, Figure 5K). Type II deiodinase
(Dio2), an enzyme responsible for conversion of the low-activity
form thyroxine (T4) to the active form 3, 30, 5-triiodothryonine
(T3), gene expression was also reduced in lPBN IL-6 KD rats,
(p < 0.05, Figure 5K). Moreover, a strong trend (p = 0.06) indi-
cated reduced UCP-1 protein in BAT (Figure 5L).
PBN IL-6 Knockdown Decreases Plasma Thyroid
Hormone Levels and BAT Sympathetic Activity
Next, we examined whether changes in hormonal (thyroid axis)
and neural (SNS innervation) CNS outputs underlie reduced
BAT thermogenesis detected in lPBN IL-6 KD rats. To determine
whether the hypothalamus-pituitary-thyroid axis is affected by
the lPBN IL-6 manipulation, we measured blood plasma levels
of T3, T4, and thyroid-stimulating hormone (TSH). Results re-
vealed a significant reduction of T3 in lPBN IL-6 KD rats
compared to controls (p < 0.05, Figure 5M), with no significant
changes detected in the levels of T4 (p = 0.16, Figure 5N) or
TSH (p > 0.05, Figure 5O). TRH gene expression in the hypothal-(G) Sum of activity from two consecutive dark phases.
(H) Sum of activity from two consecutive light phases.
(I) Representative images of infrared thermography of BAT region in control and
(J) BAT temperature as detected by infrared thermography during the light phas
(K) BAT gene expression, as detected by qPCR, of the following genes: UCP1, th
required for suppression of white-fat-selective genes in BAT and DIO2, an enzym
form 3, 30, 5-triiodothryonine (T3). Ucp1, uncoupling protein 1; Prdm16, PR dom
(L) UCP-1 protein levels in BAT in the IL-6 KD rats compared to control rats (n = 8
each treatment group.
(M) Plasma T3 levels in IL-6 KD rats and controls (n = 8, each).
(N) Plasma T4 levels.
(O) Plasma TSH levels.
(P) TRH gene expression in the hypothalamus as detected by qPCR (n = 5, each
(Q) TSHb expression in the pituitary (n = 5, each) as detected by qPCR.
(R) Quantification of TH protein expression in BAT tissue (n = 12).
(S) Representative images of TH expression (shown in brown) in BAT of controls
beta subunit; TRH, thyroxine-releasing hormone; BAT, brown adipose tissue; TH
The results presented here were derived from tissues of rats with physiology and
here as bar graphs was detected by real-time qPCR. Data represent mean ± SEamus (p < 0.05, Figure 5P) and TSHb expression in pituitary
(p < 0.05, Figure 5Q) were increased by the KD. BAT UCP1 levels
can be increased by activation of the sympathetic innervation to
BAT (Cannon and Nedergaard, 2004) or elevated T3 (Bianco and
Silva, 1987a, 1987b; Obregon, 2014). Therefore, to understand
whether the decreased BAT activity is associated with a reduced
sympathetic output to this tissue, we quantified BAT TH protein
expression, the rate-limiting enzyme in norepinephrine produc-
tion. TH protein in BAT of lPBN IL-6 KD rats was robustly reduced
(p < 0.05, Figure 5R), consistent with reduced sympathetic
output to the BAT of lPBN IL-6 KD rats.
Anxiety-like Behavior in lPBN IL-6 Loss
Central IL-6 is linked to stress-related disorders, such as depres-
sion and anxiety (Erta et al., 2015; Hodes et al., 2016), and the
lPBN has well-established neuroanatomical links to emotionality
regulating regions, such as the amygdala (Bernard et al., 1996;
Gauriau and Bernard, 2002). Therefore, we evaluated the poten-
tial impact of IL-6 loss in the lPBN on anxiety-like behavior using
two well-validated rodent tests of anxiety: the open field and the
elevated plus maze (EPM). Lateral PBN IL-6 KD rats spent less
time in center area during the open-field test (p < 0.05, Figure 6A)
and more time in the periphery (p < 0.05, Figure 6B), which may
be indicative of increased anxiety-like behavior. However, the
IL-6 KD rats also displayed lower locomotor activity during this
test (p < 0.01, Figure 6C), suggesting that changes in locomotor
activity may be a competing explanation for the open-field test
results. This idea was further supported by the lack of significant
effect on time spent in open arms of the EPM (p > 0.05, Fig-
ure 6D). Also, during the EPM test the rats with reduced lPBN
IL-6 moved significantly less compared to control rats (p <
0.05, Figure 6E). Thus, the open field and EPM results may indi-
cate a lower locomotor activity in a novel environment in IL-6 KD.
Crh gene expression in the PVH was not altered (Figure 6F).
lPBN IL-6 Is Unaffected by Acute Stress
Because locomotor activity of the IL-6 KD rats was reduced only
during exposure to a novel environment and not in the homecage
environment, we hypothesized an interaction of lPBN IL-6 withIL-6 KD.
e (n = 8 and 9, control and IL-6 KD, respectively).
ermogenesis permissive mitochondrial protein; PRDM16, a transcription factor
e responsible for conversion of the low-activity form thyroxine (T4) to the active
ain zinc-finger protein 16; Dio2, type II deiodinase.
each). Image above the graph shows the representative western blot bands for
).
and IL-6 KD, along with a negative control. TSHb, thyroid-stimulating hormone
, tyrosine hydroxylase.
metabolism assessed and displayed in Figure 4. All gene expression presented
M. *p < 0.05; **p < 0.01; ***p < 0.001; unpaired Student’s t test comparisons.
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Figure 6. Physiological Contexts Interacting
with lPBN IL-6
(A–F) Virally introduced siRNA, designed to
knockdown IL-6 gene expression, was delivered
into the lPBN, as shown in Figure 4, and anxiety-
like behavior and concurrent locomotor activity
testing was conducted in male rats 7 weeks after
siRNA introduction.
(A) Time spent in the center of an open-field arena
(n = 7–8).
(B) Time spent in the periphery of the open-field
arena.
(C) Total locomotor activity of IL-6 KD rats in
comparison to controls.
(D) Time in the open arms of the elevated plusmaze
(EPM) of IL-6 KD rats in comparison to control rats.
(E) Total locomotor activity of IL-6 KD and controls.
(F) Expression of Crh in the hypothalamus, as
detected by qPCR, in IL-6 KD and control rats.
(G) Gene expression levels of IL-6, as detected by
qPCR, in PBN of 11-week-old chow-fed rats
challenged with a 30-min acute-restraint stress
(n = 7–8).
(H and I) PBN IL-6 mRNA expression after 48-h
exposure to ambient cold in 11-week-old chow-
fed male (n = 6 per treatment group) (H) and female
(n = 7 per treatment group) rats (all from another
new cohort) (I).
(J–L) A new cohort of male mice, fed a high-fat diet
for 8 weeks prior to testing, and 13 weeks old at
the time of testing, was exposed to cold for 48 h,
and brain tissues were immediately collected after
cold exposure for testing IL-6 mRNA levels in the
PBN of (J) chow- and (K) HFD-fed mice (n = 6–10).
Comparison of IL-6 levels in the PBN of cold-
exposed chow- and HFD-fed mice (L).
All gene expression presented here as bar graphs
was detected by real-time qPCR. Data represent
mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001;
*****p < 0.00001; unpaired Student’s t test com-
parisons. OF, open field.stress. Accordingly, to further pinpoint the physiological/patho-
physiological conditions that affect lPBN IL-6, we evaluated the
effect of acute stress exposure on IL-6 gene expression levels3020 Cell Reports 26, 3011–3026, March 12, 2019in lPBN. We found that, contrary to our
hypothesis, acute stress (30-min restraint)
did not affect IL-6 gene expression levels
in the lPBN (p > 0.05, Figure 6G).
lPBN IL-6 Sensitivity to Ambient
Cold Exposure
Becausewe found a clear role of lPBN IL-6
in BAT thermogenesis, and cold exposure
engages the CNS in order to increase BAT
thermogenesis,wehypothesized that cold
exposure will increase lPBN IL-6 levels.
Indeed, IL-6 gene expression in the lPBN
was increased by 50% in male rats
exposed to 4Ccold for 48 h (p < 0.05, Fig-
ure 6H). Gene expression of IL-6 in thelPBN of female rats was unaltered by ambient cold (Figure 6I).
Additionally, chow and HFD-fed mice were exposed to 4C cold
for 48 h, and IL-6 gene expression in the lPBN was measured at
the 48-h time point. Cold exposure increased IL-6 expression in
both chow-fed (p < 0.001, Figure 6J) and HFD-fed (p < 0.0001,
Figure 6K) mice; however, the relative expression levels of IL-6
in HFD-fed cold-exposed mice were lower (p < 0.05, Figure 6L)
when compared to those in chow-fed cold-exposed mice.
Thus, cold exposure can partially restore the lPBN IL-6 loss in
obesity.
lPBN as a Source of IL-6 for the PVH
Considering the impact of PBN IL-6 manipulation on body tem-
perature and PVH-controlled HPT axis changes in the KD rats,
the possibility of a direct neuronal link between the lPBN and
PVH was further examined by a combination of retrograde
tracer, AAV2(Retro)-eSyn-EGFP (Figure 7A), injected into the
PVH (Figure 7B) and lPBN RNAscope (Figures 7E–7J). AAV-
assisted retrograde neural tract tracing indicated the presence
of retrogradedly labeled cell bodies specifically in the lPBN
(Figure 7C), with an average of 18 cell bodies identified per
each coronal section throughout the lPBN. Importantly, nearly
all retrogardely labeled cell bodies contained IL-6 mRNA (Fig-
ures 7G–7J), indicating that lPBN neurons are one potential
source of IL-6 in the PVH.
DISCUSSION
The cytokine IL-6 plays divergent roles in health and disease,
supporting healthy weight maintenance in a normal physiolog-
ical state, in addition to its role as an essential component of
inflammatory response (Lutz, 2016; Rincon, 2012). Circulating
levels of IL-6 are increased in obesity; however, these changes
do not correspond with IL-6 levels in the CNS, which, instead,
are reduced (Roytblat et al., 2000; Stenlöf et al., 2003). How
and where the CNS production of IL-6 is affected by obesity re-
mained poorly understood. Here, we show that obesity robustly
affects brain IL-6 mRNA, and it does so in a neuroanatomically
and sex-specific manner. Of the areas investigated, only lPBN
was altered by IL-6. lPBN is a nucleus not as widely investi-
gated as the hypothalamus, yet it is crucial in feeding control.
Using recent advances in molecular and genetic tools, we
were able to both localize IL-6 mRNA to neurons, astrocytes,
and microglial cell bodies in lPBN and then selectively reduce
IL-6 mRNA levels in the lPBN. This approach represents a
significant refinement to many previous reports because local-
izing IL-6 to a specific brain region proved challenging because
of a lack of reliable antibodies, and most manipulations of IL-6
involved whole body or, more recently, tissue/cell-specific
manipulations, which are not compatible with understanding
the diverse, and possibly divergent, function of IL-6 in different
CNS nuclei (Erta et al., 2015; Matthews et al., 2010; Quintana
et al., 2013; Wallenius et al., 2002b). Our complementary set
of results clearly indicates that IL-6 acts in the lPBN to reduce
the intake of chow and high-fat/high-sugar diet, and to increase
BAT thermogenesis by increasing the HPT axis activity and
sympathetic outflow. Moreover, IL-6 interacts with the adi-
pose-produced hormone, leptin, at the level of the lPBN to
reduce food intake, and its anorexic effect persists in high-
fat/high-sugar diet-fed rats. Importantly, a reduction in lPBN
IL-6 was detrimental to metabolic physiology, because it ledto increased weight gain, increased adiposity, reduced BAT
thermogenesis, and increased food intake.
Intra-lPBN delivery of exogenous IL-6 resulted in a significant
hypophagia. Conversely, consistent with the anorexigenic role of
IL-6 when delivered into the lPBN, the knockdown of IL-6 in this
nucleus produced weight gain and long-term hyperphagia in rats
fed a chow diet. The anorexic effect demonstrated here is in line
with previous data indicating that IL-6 gene expression in the
lPBN is increased by GLP-1R activation resulting in potent
anorexia (Richard et al., 2014). Our results also suggest that
the IL-6 produced in the lPBN likely acts locally within the
lPBN, as IL-6 receptors are expressed locally and IL-6 mRNA
is found in cells characterized by local peptide release: astro-
cytes, microglia, or (inter)neurons. Importantly, the lPBN IL-6
impact has the potential to extend beyond the lPBN, because
we also found that IL-6-expressing lPBN neurons innervate the
PVH. Moreover, in addition to the neuronal transport, lPBN-pro-
duced IL-6 may act at distant sites via CSF transport which has
been demonstrated for other neuropeptides (Noble et al., 2018).
Unlike the well-documented hypothalamic leptin resistance, the
hypophagic effect of intra-lPBN delivered IL-6 persisted in
obesity. However, it was not enhanced here, which was the
case for intracerebroventricularly injected mice (Timper et al.,
2017), potentially indicating that ventricular delivery of IL-6 may
primarily act on brain nuclei other than the lPBN. Nonetheless,
another study reports a blunted effect of IL-6 overexpression in
obese mice, also at the level of the hypothalamus (Hidalgo
et al., 2010). Thus, the action of endogenously versus exoge-
nously produced ligand may be the determining factor in detec-
tion of a blunted effect in obesity. This idea is also consistent with
the otherwise surprising finding, that the increased weight gain
and food intake of lPBN IL-6 KD rats disappeared in high-fat/
high-sugar diet-fed rats. However, these results are consistent
with reports on the whole-body IL-6 knockout HFD-fed mice
from the Febbraio laboratory (Matthews et al., 2010). Thus, this
phenomenon persists across species and diets. At this point,
we can only speculate on the mechanism, but the most fitting
hypothesis would be that because obesity reduces CSF and
lPBN IL-6 levels, this reductionmasks the relatively smaller effect
of the knockdown, reducing the possibility for detection of any
further phenotype changes.
We show that leptin, at the level of the lPBN, reduces food
intake, in line with previous data (Alhadeff et al., 2014b), and, in
contrast to IL-6, it does not affect thermoregulation. Because
leptin receptors share certain downstream signaling with IL-6Ra,
for example, STAT3 (Dunn-Meynell et al., 2016), leptin and IL-6
both can be classified as cytokines and are related structurally,
and both ligands produce anorexia by acting on the lPBN, we hy-
pothesized a synergistic relationship between leptin and IL-6 in
this area. In line with our hypothesis, injection of subthreshold
doses of both ligands produced a clear reduction in feeding
when co-applied to the lPBN indicating that IL-6 can amplify lep-
tin’s anorexic effects at the level of the lPBN.
The lPBN is neuroanatomically perfectly positioned to regulate
food intake but it also plays a critical role in thermogenesis. A
wealth of data suggests that it receives sensory information on
internal, as well as skin temperature (Geerling et al., 2016; Ko-
bayashi and Osaka, 2003; Sato et al., 2015; Yahiro et al.,Cell Reports 26, 3011–3026, March 12, 2019 3021
Figure 7. Lateral PBN IL-6-Expressing Neu-
rons Innervate the Paraventricular Hypo-
thalamus
(A) Retrograde viral tracer was unilaterally injected
into the paraventricular hypothalamus of two
6-week-oldmale rats at a volume of 0.5 mL. Tissues
were harvested 3 weeks later.
(B) Representative confocal image of the retro-
grade viral tracer injection site along with the
corresponding rat brain atlas slide to show the
confinement of the viral infection to the para-
ventricular hypothalamus.
(C and D) The densest PBN area of green fluores-
cent protein (EGFP)-labeled neurons was located
in the lPBN (C) and the corresponding rat brain
atlas slide (D).
(E and F) Lateral PBN-focused images show cell
bodies labeled with EGFP retrogradely carried
from the paraventricular hypothalamus without (E)
and with (F) DAPI. Interleukin-6 mRNA expression,
detected by RNAscope in situ hybridization and
shown in red, throughout the same area of lPBN.
(G–J) Four examples of high-resolution cell images
to show IL-6 mRNA (red) in the lPBN neurons
projecting to the PVH (green). The green serrated
line represents a trace of the green EGFP label
(to outline the cell body and fibers in the image)
and is superimposed on the RNAscope image in
order to reveal the signal in the cell that is
otherwise made less visible by the strong EGFP
label. Cell nuclei are labeled in blue with DAPI. 4V,
fourth ventricle; PVN, paraventricular nucleus;
PaDC, paraventricular hypothalamic nucleus,
dorsal cap; PaV, paraventricular hypothalamic
nucleus, ventral part; PaMP, paraventricular hy-
pothalamic nucleus, medial parvicellular part;
PaLM, paraventricular hypothalamic nucleus,
lateral magnocellular part; LPBI, lateral para-
brachial nucleus, internal part; LPBD, lateral par-
abrachial nucleus, dorsal part; LPBV, lateral par-
abrachial nucleus, ventral part; LPBC, lateral
parabrachial nucleus, central part; LPBE, lateral
parabrachial nucleus, external part.
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2017), and sends outputs to the forebrain and the hindbrain ther-
moregulatory hubs, including the PVH and raphe pallidus (RPa).
It is involved in the central mechanisms of cooling-induced ther-
mogenesis, and loss of PBN leads to inadequate thermogenic
adaptation in cool ambient temperatures (Geerling et al., 2016;
Kobayashi and Osaka, 2003; Yahiro et al., 2017). Our data place
IL-6 as an essential component of PBN thermoregulatory func-
tion. Acute exogenous delivery of IL-6 to the lPBN led to fast
onset hyperthermia, likely driven by increased BAT thermogene-
sis. Conversely, reduction of IL-6 production in the lPBN by
anti-IL-6 siRNA led to a persistent reduction in core and BAT
temperatures. Importantly, the observed changes in thermogen-
esis are unlikely to be driven by alterations in motor activity, as
neither exogenous IL-6 nor knockdown of IL-6 gene expression
altered home-cage locomotor activity, measured and analyzed
every minute for 2 days and 2 nights. Yet, significant changes
in body temperature were recorded during the same time period.
The molecular profile of BAT also supported reduced thermo-
genic capacity after lPBN IL-6 loss, as ucp-1, dio2, and prdm16
gene expression was potently suppressed. This idea is further
supported by reduction in UCP-1 protein in BAT. Alterations in
sympathetic nervous system output or the thyroid axis are two
critical mechanisms of CNS thermoregulatory control; both
were affected by IL-6 lPBN loss, indicating the robust multi-
pronged capacity of IL-6 to alter thermogenic output. The ther-
mogenic capacity of BAT is orchestrated by the CNS and relies
on the activity of the sympathetic nervous system (Burgi et al.,
2011; Cannon and Nedergaard, 2004; Contreras et al., 2015).
The thyroid system can act at the central level and stimulate
the sympathetic tone to increase the thermogenic activity of
BAT (López et al., 2013). Based on the direct neuroanatomical
outputs of the lPBN it is plausible that thyroid axis and sympa-
thetic output are directly affected by lPBN neurons projecting
to the PVH or RPa (Saper and Loewy, 1980). This is supported
by our data showing lPBN neuronal fibers in the PVH (a route
for potential neuronal transport of IL-6 from PBN to PVH) and
IL-6 receptor expression in the PVH (Schéle et al., 2012). Consid-
ering the diet-induced obesity-associated reduction of IL-6 in the
entire lPBN shown here, it is likely that PVH-projecting neurons
specifically also display reduced IL-6 in obesity, although future
studies should evaluate this question directly. Thus, reduced
lPBN IL-6 has the potential to affect the lPBN-PVH link; disrup-
tion in this communication may be one of the mechanisms via
which IL-6 reduction disrupts thermogenesis and exacerbates
weight gain. However, as there are relatively few PVH-projecting
neurons, it is unlikely to be the only mechanism disrupted by
lPBN IL-6 gene expression reduction. In addition to lPBN-PVH
link route, it is also possible that the reduced plasma T3 levels
are a consequence of reduced SNS output to BAT, and following
reduction of DIO2 (Castillo et al., 2011; Christoffolete et al., 2004;
Fonseca et al., 2014), both detected here. The latter idea is also
consistent with the increased TRH gene expression in the PVH.
Exposure of animals to cold environments potently triggers
thermo-effectors, including BAT thermogenesis, to maintain
body temperature. Here, we show that 48 h exposure to 4C
potently (4- to 8-fold) upregulated IL-6 gene expression in
mice, consistent with its thermogenic role demonstrated here.
Moreover, this upregulation persisted in the HFD-fed mice.This is important, because it indicates that the IL-6 deficit in
the PBN of obese mice is diet/obesity-specific and can be by-
passed by other inputs like cold exposure. Thus, cold exposure
can be utilized to ‘‘normalize’’ (though not completely) the
obesity-suppressed IL-6 levels.
However, the PBN IL-6 is still selective in its sensitivity to ther-
mogenic factors, because acute stress, shown to reliably induce
a psychogenic fever, by, for example, engaging the preoptic hy-
pothalamus temperature sensitive neurons (Kataoka et al.,
2014), did not affect lPBN IL-6 gene expression. This lack of ef-
fect under stress is also consistent with the lack of consistent
changes in the anxiety-like phenotype in lPBN IL-6 KD rats or
unaffectedCrh gene expression in the PVH of these rats. Reduc-
tion in lPBN IL-6 was associated with reduced time spent in
the center of the open field test, with no significant effect in
another test of anxiety, the EPM test. However, in both tests,
we find a reduced locomotor activity. Collectively these data
led us to conclude that it is more likely that these animals have
either a reduced tendency for novelty-induced activity and/or a
higher sensitivity for stress-induced locomotor suppression,
suggesting that some aspects of emotional reactivity are
affected. Notably, chronic unpredictable stress is associated
with elevated IL-6 in other brain regions, for example, the hippo-
campus (Tianzhu et al., 2014), again potentially indicating diver-
gence of function dictated by the neuroanatomical location.
Additionally, chronic stress was previously shown to increase
BBB permeability to peripheral circulating IL-6 (via alteration in
tight junction protein) in nucleus accumbens, and, thus, it is
possible that increased protein levels in other brain tissues after
stress reflect this process (Menard et al., 2017). Although, also
the difference in chronic versus acute stress cannot be dis-
counted when comparing the two datasets.
PBN is an important node mediating infection-associated
anorexia, and IL-6 is one of the signaling steps needed for
anorexia of infection to take place (Langhans and Geary,
2010). Although our current data clearly show that IL-6 in the
PBN is a critical element for body weight and intake homeostasis
during health, we cannot eliminate the possibility that this
pathway gets hijacked during disease or by disease-mimicking
agents (e.g., lipopolysaccharide treatment) to promote anorexia
during infection.
Several factors may have contributed to the lack of reduction
in PBN IL-6 in obese females, or lack of increase in PBN IL-6 in
cold-exposed females, in contrast to males. In fact, the relation-
ship of sex, estrogens, and IL-6 is equally complex as that of IL-6
and obesity, with estrogens reducing IL-6 in various pathological
contexts during infection or liver cancer (Liu et al., 2014; Naugler
et al., 2007). However, estradiol replacement therapy does not
alter IL-6 levels in postmenopausal women (Edwards and Mills,
2008), and higher, lower, or similar levels of IL-6 have been
measured in healthy men versus women (Giraldo et al., 2008).
Sex differences in the role of CNS produced IL-6 have already
been indicated (Erta et al., 2015). We have previously demon-
strated that estrous females have higher GLP-1R-induced IL-6
mRNA levels in the hypothalamus when circulating estrogen
levels are highest (López-Ferreras et al., 2018). Thus, is possible
that higher estrogen levels in females compared tomales protect
from obesity-driven IL-6 reduction. It is also possible that inCell Reports 26, 3011–3026, March 12, 2019 3023
females the diet simply takes longer to affect PBN IL-6; females
are able to better defend themselves against the reduction. Sex
differences in brain IL-6 production is certainly a topic that de-
serves the focused attention of a future study.
In conclusion (graphical abstract), we demonstrate that IL-6
can be produced by lPBN neurons, astrocytes, and microglia.
It acts at the level of the lPBN to reduce body weight by
increasing BAT thermogenesis and by reducing food intake,
but it can also reach CNS areas outside of the PBN (e.g., PVH).
We identify two (patho)physiological contexts, obesity and cold
exposure, which divergently affect IL-6 production specifically
in the lPBN. We also show that the obesity-induced IL-6 deficit
can be bypassed by cold exposure and that the deficit is not pre-
sent for exogenous IL-6 application. The latter point, along with
the identified here cooperative interaction of exogenously
applied IL-6 with leptin in the lPBN, highlights the emerging
potential importance of the local circuit identified here for devel-
opment of obesity therapeutics.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Five-week-old male and female C57BL/6N mice were fed regular chow (Global Diet #2016; Harlan-Teklad; 4% kcal from fat) or HFD
(catalog #D12492; Research Diets Inc.; 60% kcal from fat) over 8 weeks. Male or female Sprague-Dawley CD rats (5 weeks at arrival,
Charles River, Germany) were individually housed in cages with ad libitum access to either chow and water; or exposed to high-fat/
high-sugar diet consisting of ad libitum access to chow, in-house made 50/50% by weight sucrose/lard mixture, and water. Addi-
tional experiments (Figures 2 and S6) were conducted in rats fed chow, or obesogenic diet consisting of ad libitum access to
chow, lard, sucrose solution (30% sucrose), and water to allow for recording of intake of fat and sugar separately after treatments.
All rodents were maintained on a 12h/12h light/dark cycle. All studies were approved by the Animal Welfare Committee of the Uni-
versity of Pennsylvania or University of Gothenburg, Sweden, Ethical permit # 137/15, 195/13, and 77/15.
METHOD DETAILS
Quantitative PCR
All rat or mouse brains were rapidly extracted after light (4%) isoflurane (Baxter AB, Sweden) anesthesia, quickly frozen in isopentane
(on dry ice chamber) and transferred to 80C freezer; PBN, hypothalamus, amygdala, and hippocampus were collected. Note that
while for rat brain dissections lPBN was reliably dissected, in mice the dissections likely encompassed lateral and dorsal parts of the
mPBN. Total RNA was extracted using RNeasy Lipid Tissue Mini kit (QIAGEN) with additional deoxy ribonuclease treatment
(QIAGEN), or using PicoPureTM RNA isolation kit (Thermofisher). RNA quality and quantity were assessed spectrophotometrically
by Nanodrop 1000 (NanoDrop Technologies). cDNA was synthesized using iScript cDNA Synthesis kit from Bio-Rad. Real-time
RT-PCR was performed using TaqMan probes, and selective primer sets described in the key resource table.
Gene expression values were calculated based on the DDCt method (Livak and Schmittgen, 2001). For initial assessment of gene
expression changes in mice each group consisted of 10 mice (per diet and per sex). For rats: 5 males were included in each diet
group, and 11 females were included in the chow group and 12 in the HFSD group.
Drugs
Rat IL-6, or leptin, (Peprotech, Inc. United Kingdom) were dissolved in artificial cerebrospinal fluid, aCSF (Tocris, United Kingdom).
Intracranial cannulation and injections
Intra-lPBN cannulation and injections were performed in male rats. Guide cannula (26 gauge; Plastics One, USA) targeting the lPBN
was implanted under ketamine: xylazine (3:1 mix; dosage 0.4 ml/240 g) anesthesia. Cannulas were secured on the skull using stain-
less steel screws and dental cement. The coordinates for cannula implants were 2.0/-9.2/4 mm (midline/bregma/skull, respectively)
(Richard et al., 2014). The injector was aimed 6.5mmventral to skull. LPBN-targeted unilateral infusions of IL-6 (0.2 mg in aCSF), leptin
(0.1 or 1 mg in aCSF) or aCSF were performed with a 0.5 ml injection volume at the rate 1 ml/min using a micro-infusion pump. For
synergy experiments, subthreshold doses of leptin and IL-6 (0.1 mg for both drugs) were used; these doses are based on the feeding
effect of both ligands. For the combination of leptin and IL-6, premixed leptin and IL-6 were delivered. All injections were performed in
a counterbalanced Latin square design, where each animal received each treatment. Each injection daywas separated by at least 48.
Cannula placements and injectate volume spread were confirmed using 15mM brain sections, fixed and stained with DAPI and
observed under epifluorescence microscope. Rats with cannulas outside of the lPBN were eliminated from the study.
lPBN IL-6 gene knockdown
AAV construct iAAV01087702 (IL-6 AAV siRNA pooled virus Serotype 2) and control construct iiAAV01502 (Scrambled AAV siRNA
control virus Serotype 2) titer 1012 GC/ml were purchased fromABM (Richmond, Canada). Both constructs contain EGFP fluorescent
markers. AAVswere injected at the rate of 0.1 ml/min (0.4 ml per hemisphere), using the lPBN coordinates as described above, and the
injectors were left in place for 10min post-injection to allow diffusion away from injection site. Food intake and body weight of the rats
were followed daily for four weeks (n = 17 for each treatment group). Following the four-week period of undisturbed intake andweight
measurements, body temperature (n = 8 in each group), home-cage activity (n = 8 in each group), BAT temperature (n = 8 in each
group), and anxiety-like behavior were tested as described above. For terminal tissue collection, rats were decapitated under
isoflurane anesthesia and brain and adipose tissues were collected and stored in 80 C freezer for immunohistochemistry or
gene expression analysis.
Acute food intake measurements
Acute effect of IL-6 injections on food intake was measured in lean (n = 13) and HFSD-fed rats (n = 9). For lean rats the intake was
measured at 1 and 6h, and for HFSD-fed rats intake of lard, chow, and sucrose solution (all foods were a part of the HFSD mainte-
nance diet) was measured at 6h after injections. In both groups injections and measurements were done during light phase. The
HFSD-fed rats were on the diet for 3 weeks at the time of testing. For assessment of the intra-PBN leptin injections, chow intake
was recorded via automated feedometers that continuously measured food intake to the nearest ± 0.1 g/m/24h. Six rats were tested
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Telemetric measurements
For continuous, home-cage, measurements of core temperature, activity and heart rate with telemetric transponders, a small lateral
incision was made and the transmitter was implanted in abdominal cavity. For heart rate measurements two subcutaneous leads
were positioned on either side of the heart and sutured to the chest muscles. The body of the transmitter was sutured to the abdom-
inal muscle to secure its position. The skin was closed using sterile non-absorbable silk suture. Rats were allowed to recover for at
least five days post-surgery. For central IL-6 injection experiments (Figure 2), rats (n = 8) were implanted with an intraperitoneal tele-
metric radio transmitter, E-mitter-G2 (Minimitter, OR) and immediately after brain guide cannula placement surgery. For experiments
with central injections of leptin (Figure 3) HRC 4000 VitalView (Minimitter, OR) were utilized (n = 18).
Brown adipose tissue (BAT) temperature measurements
Skin temperature above the BAT region was measured using FLIR T500-Series thermal camera and analyzed using FLIR tools soft-
ware as previously described (Lee et al., 2018; Martinez-Sanchez et al., 2017; Matesanz et al., 2017) (n = 7 for IL-6 injections, n = 12
for the leptin/IL-6 interaction experiment). The infrared camera was utilized for measuring skin temperature directly above the BAT
region of the rats. Preliminary observations indicated that more reliable results are obtained when the skin region above BAT is not
covered by fur, therefore a defined region above BATwas shaved two days before obtaining thermal images. Four to five consecutive
images were taken in the home-cage environment per rat from a fixed distance and the average temperature was used for data anal-
ysis. Additionally, to assess the possibility of cooperative or opposing (to the changes in core temperature driven by BAT) changes in
tail blood perfusion, infrared images of the tails were taken, and tail surface temperature was scored at themid and tip level of the tail.
Anxiety-like behavior evaluation
Standard elevated plus maze (EPM) apparatus for rats (Med-Associates, Georgia, VT, USA) (n = 7 in each group) or open field
apparatus (n = 8 for controls and n = 7 for kd) for rats was utilized for quantifying anxiety like behavior. EPMwas placed 70 cm above
ground, consisted of two open arms, 503 10 cm, and two closed arms 503 103 40 cm and a central square platform 103 10 cm.
Rats were acclimatized to the EPM room for 30 minutes and then placed on the central platform and allowed to move freely for
5 minutes. The amount of time spent on each arm was detected by measuring beam breaks of infrared lasers and recorded with
MED-SYST-8A PCI operating and software package, provided by Med-Associates. The apparatus was cleaned with water between
each test subject. Immediately post EPM, the rats were placed in a brightly lit arena (90 3 90 3 30 cm, Med-Associates, VT, USA)
for 15 minutes for the open field test. The open field chambers were equipped with a grid of photocells for detecting movement.
Photocells were coupled to a computer-based system that registers movements and time spent in each section (center or periphery)
of the arena. Both EPM and open field were carried out during the light cycle.
Acute Stress
Restraint stress was used to test whether acute stress leads to increased lPBN IL-6 mRNA level and lPBN of the stressed (n = 7) and
control (n = 8) rats was collected for gene expression analysis. Rats in the acute stress group were restrained for 30 minutes (tests
performed in the light cycle between 09:00 and 15:00 hours) in standard restraining devices (Maniscalco et al., 2015; Ulrich-Lai et al.,
2010, 2011, 2015), while control rats were left undisturbed in their home cages. Immediately following acute stress the rats were
anesthetized using isoflurane followed by decapitation. The brains were then quickly removed and flash frozen using isopentane
on dry ice.
Blood biochemistry
Plasma levels of TSH, T3 and T4 in control and lPBN IL-6 knockdown rats (n = 8, each) were measured using rat ELISA kits (López
et al., 2010; Martinez-Sanchez et al., 2017; Varela et al., 2012). Trunk blood was collected in regular Eppendorf tubes and spun at 10
000 rpm for 10 minutes and the top layer (plasma) was transferred to a new tube and stored in80C. Levels of TSH, T3 and T4 were
measured using rat ELISA kits (Crystal Chem, Illinois, USA. Total T3 ELISA/T4 ELISA/TSH ELISA kits are competitive ELISAs for
T3/T4/TSH. We utilize a labeled antigen conjugated with an HRP and a monoclonal T3/T4/TSH antibody bound through a secondary
antibody on the microplate wells. The unlabeled antigen present in the test samples and standards is incubated in microplate with
HRP labeled antigen. Both labeled and unlabeled antigens compete for binding to the T3/T4/TSH antibody immobilized to the micro-
plate. After incubation, all unbound antigens are removed via a wash step. Subsequently, a substrate solution and stop solution are
added, and T3/T4/TSH levels of the samples were measured by color intensity.
Brown adipose tissue immunohistochemistry
BAT tissue tyrosine hydroxylase (TH) immunohistochemistry was performed in knockdown (n = 14) and control (n = 13) rats since the
knockdowns showed a reduced BAT temperature and downregulation of thermogenesis related genes. BAT tissue was cut in 8 mm
sections and placed on glass slides to dry for 30minutes at room temperature. The tissue was then fixed using 10%buffered formalin
(VWR Chemicals, Stockholm, Sweden) for 10 minutes, washed with tris buffered saline (1x, 5 minutes), quenched with 3% hydrogen
peroxide in methanol (20 minutes), and washed in TBS (2x). Tissue permeabilization was done using 500 ml of TBST 0,1% (tween 20)
for 20 minutes. After permeabilization, blocking was performed using 1% BSA in TBST 0.1, 5% secondary host serum (goat serum)
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lab., Inc, CA) was performed. Post-blocking, 200 ml of 1:150 TH primary antibody (BioSite Cat#LS-B3443) was added to each slide,
except for negative controls, and left overnight at 4C. Primary antibody was washed off using TBST 0.1% (4x) and secondary anti-
body (1:400 dilution, biotinylated anti-rabbit, goat source, BA-1000, Vector lab., Inc, CA) was then added to each slide, including
negative controls, and left for 30minutes. After TBSTwash (4x), ABCmixwas added to each tissue slide and incubated for 40minutes
at room temperature. DAB substrate (DAB substrate kit, ab64238, Abcam) was used for development in PBS (pH 7.4). Dehydration
was performed with ethanol (70, 95 and 100%) and xylene (1 minute each). Entellan new (Merck, Cat#107961) was used as a
mounting medium. Images were analyzed using image thresholder and expressed as % area of total area using IMAGEJ (https://
imagej.nih.gov/ij/).
In situ hybridization using RNAScope
In situ hybridization for IL-6 mRNA using RNAscope Multiplex Fluorescent kit (Advanced Cell Diagnostics) was utilized to detect IL-6
in brain tissue. To determine IL-6 presence in neuronal, glial, or microglial cells, IL-6 mRNA and mRNA for established markers of
each cell type were assessed using RNAscope. Briefly, 10-week-old male rats were sacrificed and their brains were flash frozen.
Twelve mm thick lPBN-containing brain sections were cut and fixed in 10% formalin (Thermofisher scientific, Waltham, MA) for
30 minutes on ice. Following two quick washes in PBS, brain slices were dehydrated in 50% (5 minutes), 70% (5 minutes) and
2x100% (5 minutes each) ethanol and treated with protease solution (pretreatment IV, ACDbio kit) at room temperature for an
hour. The protease was washed away with PBS for a total time of 15 minutes. Target probes and negative control probes were
applied directly on the sections to cover them completely and incubated at 40C for 2 hours in the HybEZ oven. Next, slides were
incubated with preamplifier and amplifier probes (AMP1, 40C for 30 minutes; AMP2, 40C for 15 minutes; AMP3, 40C for
30 minutes). Next, slides were incubated with fluorescent labels (AMP4-Alt A or Alt C). Finally, brain sections were incubated for
30 s with DAPI and mounting medium for fluorescence (VECTASHIELD, USA). Fluorescent images of the lPBN were captured
with 40x water immersion magnification lens using LSM700 Zeiss confocal microscope and processed using Zen lite software.
Approximate quantification strategy, described previously (Timper et al., 2017), was performed on 320 3 320 mm sections of the
lPBN. Sections for three male rats were processed for each cell type marker and IL-6. In short, a border of 2 mm was drawn around
all nuclei in the obtained images and the cells outlined in this manner were scored for absence or presence of the in situ signal for Il-6
mRNA, or the three respective neuronal markers. An average number of IL-6mRNApositive cells was confirmed to be similar for each
of the cell type markers tested (30% of cells were IL-6 positive), to ensure IL-6 detection consistency when combined with different
in situ probes.
RNAScope for fixed frozen sections
Twenty mm thick perfused brain sections were air-dried for 30 minutes. Target retrieval was performed where brain sections were
incubated at 99C in a Retrieval Solution for 7.5 minutes (ACDbio), washed 3-5 times with milliQ water and dehydrated for 15 s in
100% ethanol. Protease 3 (ACDbio) was applied for 1 hour at 40C in the HyBEZ oven. The protease was washed off with milliQ
3-5 times. Target probe for IL-6 (Rn-IL-6-C3 427141-C3) and negative control probes were applied directly on the sections to cover
them completely and incubated at 40C for 2 hours in the HybEZ oven. Next we applied preamplifier and amplifier probes (AMP1,
40C for 30 minutes; AMP2, 40C for 15 minutes; AMP3, 40C for 30 minutes; AMP4-Alt B for 15 minutes). Finally, brain sections
were incubated for 30 s with DAPI and mounting medium for fluorescence (VECTASHIELD, USA). Fluorescent images of the lPBN
were captured under with 40x water immersion magnification lens using LSM700 Zeiss confocal microscope and processed using
Zen lite software.
Acute cold exposure
Chow (n = 9 and n = 6 for control and cold-exposed respectively) or HFD-fed (8-week period; n = 10 and n = 6 for control and cold-
exposed respectively) male mice were housed at 4 C for 48h in cold chamber (Memmert HPP 750). To determine whether the effect
of cold is robust and translates across species in a second experiment male (n = 6 per each temperature condition) and female (n = 7
per each condition) rats were also tested with ambient cold exposure. Sacrifice and brain collection were performed as described
above.
Cold exposure in mice
Male mice fed either HFD or chow for 8 weeks were acutely exposed to 4 C for 48 hours in their respective home cages.
Cold exposure in rats
A stepdown cold exposure protocol was utilized for rats. In brief, the temperature was decreased gradually from room temperature to
4C in 6 hours, following which the temperature remained at 4C for the rest of the period (48 hours in total). Control rats were housed
at room temperature.
Immediately after cold exposure rodents were anesthetized using isoflurane followed by decapitation. The brains were quickly
frozen using isopentane on dry ice and stored at 80 C.Tissue punches of PBN were collected in a Leica 3050S cryostat.
Protein extraction and western blot
Interscapular BAT was dissected immediately after sacrifice, frozen in liquid nitrogen and then stored in -80C. Protein extraction
was performed using Cell lysis buffer (Cell Signaling) with added protease inhibitor. Next, tissue was mechanically lysed using steele4 Cell Reports 26, 3011–3026.e1–e5, March 12, 2019
beads at 2Hz for 2 minutes; the mix was left on a shaker for 2 hours at 4C and spun at 12000 rpm for 20 minutes. Protein concen-
trations were determined with Bradford assay. Laemmli loading buffer and beta-mercaptoethanol mix was added to the samples, the
mix was heated at 95C for 5 minutes, and fractionated by gel electrophoresis on 4%–20% (vol/vol) Stain free gel (Biorad). Proteins
were transferred on polyvinyldifluoride membranes using the Trans-Blot Turbo Transfer Pack (Biorad). Blocking of membrane was
performed with filtered 5% BSA (wt/vol) in TBS–Tween 20 buffer (TBST, 10 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 8.0)
for 1 hour. Following two TBST washes, the blots were incubated with primary antibody Ucp-1 ab10983 (Abcam; 1:1000 dilution)
overnight at 4C. Themembraneswerewashed four times for 15minutes in TBST and incubatedwith secondary antibody (Anti-rabbit
IgG HRP-linked antibody; catalog #7074 Cell Signaling) for 1 hour. Protein bands were developed using Pierce ECLWestern Blotting
Substrate and visualized with Chemidoc System from Biorad. Band analysis was performed using Image Lab program provided by
Biorad.
Neural tract tracing: Brain tissue preparation and imaging
For retrograde adeno-associated virus vector (AAV)-assisted neural tract tracing, retrograde AAV vector expressing EGFP under the
enhanced synapsin promoter; AAV2(Retro)-eSyn-EGFP was injected unilaterally to the PVH of two rats. Three weeks after viral
infusions, rats were perfused, brains were isolated, sectioned and processed for IL-6 (using in situ hybridization protocol) and
DAPI. EGFP (green), RNAscope IL-6 signal (red), and DAPI (blue) were visualized and captured with a confocal microscope.
In detail: Volume of 0.5 mL of AAV2(Retro)-eSyn-EGFP (1.2x10̂ 13 GC/ml) (Vector Biolabs, Malvern, PA, USA) was unilaterally
injected at a speed of 0.1ml/min into the PVH using a Hamilton Neuro 10 mL syringe with a 33 gauge needle, the needle was left in
place for 10 min to allow diffusion of the viral vector (Hamilton Co. Reno, NV, USA) PVN was targeted using the following coordinates
in relation to the bregma and skull surface: anterior-posterior: 1.6 mm and mediolateral: 0.3 mm and 8.3 mm dorsal. Three
weeks after viral infusions, animals received a terminal dose of a mixture of ketamine:xylazine prior to perfusion. For perfusion,
the heart was exposed and prepared with a cannula attached to a perfusion pump (Watson 120S, Watson-Marlow Fluid Technology
Group,Wilmington, MA, USA). Cold saline solution was circulated for 3-4minutes at a rate of 60ml/min and then ice –cold filtered 4%
paraformaldehyde-PBS solution was ran at a volume equal to the body weight. Brains were isolated and incubated in 15% Sucrose
4% PFA-PBS solution overnight and placed in 30% sucrose-PBS solution until saturation. Samples were frozen on CO2-ice prior to
brain sectioning with a Leica 3050S cryostat (Leica Biosystems Nussloch GmbH, Nussloch, Germany). 20 mm coronal slices were
collected on SuperFrost+ sample glasses (Thermo scientific, Waltham, MA, USA) and stored at - 80C. For co-localization of IL-6
mRNA and the retrograde EGFP signal, 20 mm thick sections were processed as described above in RNAScope for fixed frozen
sections. Images were captured using a Zeiss LSM700 confocal microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). Tiles
images of 10x (air) and 40x (water immersion) were taken throughout the PBN in multiple layers with a depth of 1-3 mm (5-6 levels) in
order to convert the images with the Maximum Projection-software (Zen software, Carl Zeiss Microscopy GmbH, Jena, Germany) for
increased depth range. Coronal brain atlas figures (Paxinos & Watson 6th edition) were superimposed on the fluorescent images of
the PBN sections (sections throughout the PBN were analyzed from two male rats).
QUANTIFICATION AND STATISTICAL ANALYSIS
All the data are presented asmean ±SEM. Statistical significancewas analyzed using Student’s t test for comparisons of two groups,
or one- or two-way ANOVA with post hoc Sidak’s tests when appropriate (GraphPad Software, Inc). p < 0.05 was considered
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